Heparin and maternal fetal interface: Why should it work to prevent pregnancy complications?

Thrombosis Research

Volumn 124, Issue 6, 2009, Pages 653-655

  Hossain, Nazli ^a   Schatz, Frederick ^b   Paidas, Michael J ^b,c,d  

^a CIVIL HOSPITAL   (Pakistan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yale Women and Children's Center for Blood Disorders   (United States)

^d National Hemophilia Foundation   (United States)

Author keywords

adverse pregnancy outcome; anticoagulant therapy; maternal fetal interface

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; LOW MOLECULAR WEIGHT HEPARIN; MATRIX METALLOPROTEINASE; PROTEINASE; PROTHROMBIN; SELECTIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; APOPTOSIS; BLOOD PLACENTA BARRIER; CELL ADHESION; CELL INVASION; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG MECHANISM; FERTILIZATION IN VITRO; FETOPLACENTAL UNIT; HIGH RISK POPULATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; NIDATION; NONHUMAN; OUTCOME ASSESSMENT; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT ABORTION; REVIEW; SOLUTIO PLACENTAE; THROMBOPHILIA; THROMBOSIS; TROPHOBLAST;

ANTICOAGULANTS; COMPLEMENT SYSTEM PROTEINS; FEMALE; FETAL DEATH; HEPARIN; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; RISK; THROMBOPHILIA;

EID: 70449529643     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.08.001     Document Type: Review

References (30)

1. Challis J.R., Lockwood C.J., Myatt L., Norman J.E., Strauss III J.F., and Petraglia F. Inflammation and pregnancy. Reprod Sci 16 2 (2009) 206-215
2. Park J.S., Park C.W., Lockwood C.J., and Norwitz E.R. Role of cytokines in preterm labor and birth. Minerva Ginecol 57 4 (2005) 349-366
3. Lok C.A., Jebbink J., Nieuwland R., Faas M.M., Boer K., Sturk A., et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol 61 5 (2009) 346-359
4. Lockwood C.J. Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 49 4 (2006) 836-843
5. Halligan A., Bonnar J., Sheppard B., Darling M., and Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 101 6 (1994) 488-492
6. Paidas M.J., Ku D.H., Urban G., Hossain N., Rebarber A., Lockwood C.J., et al. Elevated first trimester soluble fibrin polymer is associated with adverse pregnancy outcome in thrombophilic patients. Blood Coagul Fibrinolysis 19 8 (2008) 824-826
7. Tyrell D.J., Kilfeather S., and Page C.P. Therapeutic uses of heparin beyond its traditional role as an anticoagulant. Trends Pharmacol Sci 16 6 (1995) 198-204
8. Salmon J.E., Girardi G., and Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation. Trans Am Clin Climatol Assoc 118 (2007) 99-114
9. Mulla M.J., Brosens J.J., Chamley L.W., Giles I., Pericleous C., Rahman A., et al. Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88, pathway. Am J Reprod Immunol 62 2 (2009) 96-111
10. Hills F.A., Abrahams V.M., Gonzalez-Timon B., Francis J., Cloke B., Hinkson L., et al. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 12 4 (2006) 237-243
11. Bose P., Black S., Kadyrov M., Weissenborn U., Neulen J., Regan L., et al. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol 192 1 (2005) 23-30
12. Di Simone N., Di Nicuolo F., Sanguinetti M., Ferrazzani S., D'Alessio M.C., Castellani R., et al. Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Placenta 28 4 (2007) 298-304
13. Gris J.C., Dekker G., and Cohen H. Antithrombotic prophylaxis for pregnancy loss Prothrombotic mechanisms in preeclampsia Inherited thrombophilia and pregnancy loss-epidemiology. Thromb Res 115 Suppl 1 (2005) 30-32
14. Paidas M.J., Ku D.H., Lee M.J., Manish S., Thurston A., Lockwood C.J., et al. Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 3 3 (2005) 497-501
15. Riyazi N., Leeda M., de Vries J.I., Huijgens P.C., van Geijn H.P., and Dekker G.A. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 80 1 (1998) 49-54
16. Sibai B.M. Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies?. Hypertension 46 6 (2005) 1252-1253
17. Weiner Z., Beck-Fruchter R., Weiss A., Hujirat Y., Shalev E., and Shalev S.A. Thrombophilia and stillbirth: possible connection by intrauterine growth restriction. Bjog 111 8 (2004) 780-783
18. Kupferminc M.J., Fait G., Many A., Lessing J.B., Yair D., Bar-Am A., et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 20 1 (2001) 35-44
19. Hossain N., Shamsi T., and Soomro N. Frequency of thrombophilia in patients with adverse pregnancy outcome. J Pak Med Assoc 55 6 (2005) 245-247
20. Wu O., Robertson L., Twaddle S., Lowe G.D., Clark P., Greaves M., et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS), study. Health Technol Assess 10 11 (2006) 1-110
21. Rey E., Garneau P., David M., Gauthier R., Leduc L., Michon N., et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 7 1 (2009) 58-64
22. Nelson S.M., and Greer I.A. The potential role of heparin in assisted conception. Hum Reprod Update 14 6 (2008) 623-645
23. Qublan H., Amarin Z., Dabbas M., Farraj A.E., Beni-Merei Z., Al-Akash H., et al. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled, trial. Hum Fertil (Camb) 11 4 (2008) 246-253
24. Brenner B., Hoffman R., Carp H., Dulitsky M., and Younis J. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX, study. J Thromb Haemost 3 (2005) 227-229 (2%R doi:10.1111/j.1538-7836.2004.01090.x)
25. Paidas M., Ku D.H., Triche E., Lockwood C., and Arkel Y. Does heparin therapy improve pregnancy outcome in patients with thrombophilias?. J Thromb Haemost 2 7 (2004) 1194-1195
26. Urban G., Vergani P., Tironi R., Ceruti P., Vertemati E., Sala F., et al. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. Int J Fertil Womens Med 52 2-3 (2007) 59-67
27. Grandone E., De Stefano V., Rossi E., Cappucci F., Colaizzo D., and Margaglione M. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis 19 3 (2008) 226-230
28. Folkeringa N., Brouwer J.L., Korteweg F.J., Veeger N.J., Erwich J.J., Holm J.P., et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol 138 1 (2007 Jul) 110-116
29. Duhl A.J., Paidas M.J., Ural S.H., Branch W., Casele H., Cox-Gill J., et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 197 5 (2007) 457 e1-21
30. Rodger M.A., Paidas M., Claire M., Middeldorp S., Kahn S., Martinelli I., et al. Inherited Thrombophilia and Pregnancy Complications Revisited. Obstet Gynecol 112 2 (Aug 2008) 320-324